“We have made the decision to proactively delay the rollout of our vaccine in Europe” says Johnson and Johnson over concern surrounding blood clot side effects.
They’ve clearly seen the PR disaster it’s been for AstraZeneca and don’t want the harm to their brand name. pic.twitter.com/HJfpLlSJdH
— Jack Parrock (@jackeparrock) April 13, 2021
COVID-19: US recommends ‘pause’ to Johnson & Johnson jab rollout over blood clot fears https://t.co/p81jwczoqn
— Sky News (@SkyNews) April 13, 2021
Further to concerns over the link between the Oxford-AstraZeneca vaccine and blood clots…
…The US Food and Drug Administration has recommended a “pause” to the rollout of the Johnson & Johnson COVID vaccine so it can investigate reports of… blood clots.
The single dose vaccine has been given to 6.8 million Americans.
— Robbie (@Rocketpants_) April 13, 2021